Advantis Medical Imaging is a pioneering manufacturer of cloud-based medical imaging software solutions, with a focus on making medical image analysis more quantitative, accessible, and automated through AI and cloud technology. Their flagship product, Brainance MD, is an FDA cleared and CE Marked advanced neuroimaging platform intended for the display and processing of multiple brain MRI sequences in a unified and highly intuitive user web-interface. This fully DICOM compliant application is provided as a Software as a Service (SaaS) and offers analysis and visualization capabilities of dynamic MRI data of the brain, presenting the results in a clinically useful context and further assisting clinicians during the diagnostic workflow of brain MRI exams. Advantis Medical Imaging also aims to offer a holistic and automated imaging suite, which covers a wide spectrum of medical image processing needs and pathologies, having already expanded its platform to multiparametric prostate MR imaging. Founded in 2016 and headquartered in The Netherlands, the company received a €700.00K Seed Round investment on 08 March 2019 from Metavallon VC. The company operates in the Health Care industry.
No recent news or press coverage available for Advantis Medical Imaging.